Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Brentuximab Vedotin und Kombinationschemotherapie bei der Behandlung von Kindern und jungen Erwachsenen mit Hodgkin-Lymphom im Stadium IIB, IIIB, IVA oder IVB

10. November 2026 aktualisiert von: National Cancer Institute (NCI)

Eine randomisierte Phase-3-Studie zu Brentuximab Vedotin (SGN-35) bei neu diagnostiziertem klassischem Hodgkin-Lymphom (cHL) mit hohem Risiko bei Kindern und jungen Erwachsenen

This phase III trial studies brentuximab vedotin and combination chemotherapy to see how well they work compared to combination chemotherapy alone in treating children and young adults with stage IIB with bulk, stage IIIB, IVA, or IVB Hodgkin lymphoma. Combinations of biological substances in brentuximab vedotin may be able to carry cancer-killing substances directly to Hodgkin lymphoma cells. Chemotherapy drugs, such as doxorubicin hydrochloride, bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known if combination chemotherapy is more effective with or without brentuximab vedotin in treating children with high-risk Hodgkin lymphoma.

Studienübersicht

Status

Aktiv, nicht rekrutierend

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

PRIMARY OBJECTIVE:

I. To assess the event free survival (EFS) of a novel regimen incorporating brentuximab vedotin (Bv; Adcetris) in the chemotherapy backbone of doxorubicin hydrochloride (doxorubicin) (Adriamycin), vincristine sulfate (vincristine), etoposide, prednisone and cyclophosphamide (Bv-AVEPC) in newly diagnosed high-risk classical Hodgkin lymphoma (cHL) compared to those treated with Adriamycin, bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide (ABVE-PC).

SECONDARY OBJECTIVES:

I. To determine whether children/young adults with high-risk cHL treated with Bv-AVEPC have a higher rate of early response (determined by fludeoxyglucose F 18 [FDG]-positron emission tomography [PET]) and a reduction in protocol directed radiation therapy (RT) compared to those treated with ABVE-PC.

II. To compare the rate of neuropathy (>= grade 3) among patients treated on the Bv-AVEPC (experimental arm) to patients treated on the ABVE-PC (standard arm).

EXPLORATORY OBJECTIVES:

I. To validate and compare the Childhood Hodgkin International Prognostic Score (CHIPS) to conventional Ann Arbor stage (stages II B with bulk, III B, IV A or B) in predicting outcome in high-risk childhood cHL.

II. To determine the incidence of preferentially expressed antigen in melanoma (PRAME) and testis-specific antigens in Epstein-Barr virus (EBV)- cHL tumors and the incidence of EBV antigens (Epstein-Barr nuclear antigen 1 [EBNA1], Epstein-Barr virus latent membrane protein 1 [LMP1], large multifunctional peptidase 2 [LMP2]) in EBV+ cHL tumors, with the goal of developing strategies to integrate cellular therapy into treatment for newly diagnosed high-risk cHL. (Biology) III. To incorporate qualitative visual FDG-PET into response-directed treatment algorithms and explore quantitative FDG-PET and computed tomography (CT) definitions of tumor burden and response for incorporation into next generation pediatric cHL risk-stratification schemes, exploring the extension of these algorithms to young adults. (Imaging) IV. To evaluate the reduction in normal tissue irradiation associated with the current treatment approach compared to the volume of historic involved field radiation therapy (IFRT) fields. (Radiation Therapy) V. To evaluate EFS and patterns of relapse following protocol-specified RT utilization and treatment volumes. (Radiation Therapy) VI. To characterize the extent of chemotherapy induced peripheral neuropathy (CIPN), as reported by patients and parent proxies, through serial administration of the Functional Assessment of Cancer Therapy-Gynecologic Oncology Group-Neurotoxicity (FACT-GOG-NTX). (Patient Reported Outcomes [PRO] of Peripheral Neuropathy and Health-Related Quality of Life) VII. To describe the Health-Related Quality of Life (HRQL) consequences of peripheral neuropathy over time by correlating total neuropathy scale scores with the individual items with the Child Health Ratings Inventories (CHRIs)-Global scale (e.g., physical health, pain, emotional functioning). (PRO of Peripheral Neuropathy and Health-Related Quality of Life) VIII. To perform a cross validation of the FACT-GOG-NTX with the Total Neuropathy Score-Pediatric Vincristine (TNS-PV) to determine the performance of both measures with the use of brentuximab vedotin in a limited institutional approach in children and adolescents with cHL. (PRO of Peripheral Neuropathy and Health-Related Quality of Life) IX. To assess the resource use and cost implications of Bv in combination with chemotherapy and radiotherapy (RT) for newly diagnosed high-risk cHL in children and young adults. (Economic) X. To estimate the risk of relapse among rapidly responding lesions (RRL) subjects that have at least one lesion that is Deauville 3 at PET 2. (Follow-up of Deauville score 3 lesions on FDG-PET imaging [confirmed by central imaging review]) XI. To characterize the pharmacokinetics of brentuximab vedotin in children < 13 years of age.

OUTLINE: Patients are randomized to 1 of 2 treatment arms.

ARM I (ABVE-PC): Patients receive doxorubicin hydrochloride intravenously (IV) over on days 1-2, bleomycin sulfate IV or subcutaneously (SC) on days 1 and 8, vincristine sulfate IV on days 1 and 8, etoposide IV on days 1-3, prednisone orally (PO) twice daily (BID) or methylprednisolone IV on days 1-7, and cyclophosphamide IV on days 1 and 2.

ARM II (Bv-AVEPC): Patients receive brentuximab vedotin IV on day 1. Patients also receive doxorubicin hydrochloride, etoposide, prednisone or methylprednisolone, and cyclophosphamide as in Arm I and vincristine sulfate IV on day 8.

In both arms, treatment repeats every 21 days for 5 cycles in the absence of disease progression or unacceptable toxicity. Granulocyte simulating factor (GCSF) or equivalent is given on both arms.

After completion of study treatment, patients are followed up at 3, 6, 9, 12, 18, 24, 30, 36, and 48 months.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

600

Phase

  • Phase 3

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

      • Québec, Kanada, G1V 4G2
        • CHU de Quebec-Centre Hospitalier de l'Universite Laval (CHUL)
    • Alberta
      • Calgary, Alberta, Kanada, T3B 6A8
        • Alberta Children's Hospital
      • Edmonton, Alberta, Kanada, T6G 2B7
        • University of Alberta Hospital
    • British Columbia
      • Vancouver, British Columbia, Kanada, V6H 3V4
        • British Columbia Children's Hospital
    • Manitoba
      • Winnipeg, Manitoba, Kanada, R3E 0V9
        • CancerCare Manitoba
    • Nova Scotia
      • Halifax, Nova Scotia, Kanada, B3K 6R8
        • IWK Health Centre
    • Ontario
      • Hamilton, Ontario, Kanada, L8N 3Z5
        • McMaster Children's Hospital at Hamilton Health Sciences
      • Kingston, Ontario, Kanada, K7L 2V7
        • Kingston Health Sciences Centre
      • London, Ontario, Kanada, N6A 5W9
        • Children's Hospital
      • Ottawa, Ontario, Kanada, K1H 8L1
        • Children's Hospital of Eastern Ontario
      • Toronto, Ontario, Kanada, M5G 1X8
        • Hospital for Sick Children
    • Quebec
      • Montreal, Quebec, Kanada, H3H 1P3
        • The Montreal Children's Hospital of the MUHC
      • Montreal, Quebec, Kanada, H3T 1C5
        • Centre Hospitalier Universitaire Sainte-Justine
    • Saskatchewan
      • Saskatoon, Saskatchewan, Kanada, S7N 4H4
        • Saskatoon Cancer Centre
      • Caguas, Puerto Rico, 00726
        • HIMA San Pablo Oncologic Hospital
      • San Juan, Puerto Rico, 00926
        • University Pediatric Hospital
      • San Juan, Puerto Rico, 00912
        • San Jorge Children's Hospital
    • Alabama
      • Birmingham, Alabama, Vereinigte Staaten, 35233
        • Children's Hospital of Alabama
      • Mobile, Alabama, Vereinigte Staaten, 36604
        • USA Health Strada Patient Care Center
    • Alaska
      • Anchorage, Alaska, Vereinigte Staaten, 99508
        • Providence Alaska Medical Center
    • Arizona
      • Mesa, Arizona, Vereinigte Staaten, 85202
        • Banner Children's at Desert
      • Phoenix, Arizona, Vereinigte Staaten, 85016
        • Phoenix Childrens Hospital
      • Tucson, Arizona, Vereinigte Staaten, 85719
        • Banner University Medical Center - Tucson
    • Arkansas
      • Little Rock, Arkansas, Vereinigte Staaten, 72202-3591
        • Arkansas Children's Hospital
    • California
      • Downey, California, Vereinigte Staaten, 90242
        • Kaiser Permanente Downey Medical Center
      • Duarte, California, Vereinigte Staaten, 91010
        • City of Hope Comprehensive Cancer Center
      • Loma Linda, California, Vereinigte Staaten, 92354
        • Loma Linda University Medical Center
      • Long Beach, California, Vereinigte Staaten, 90806
        • Miller Children's and Women's Hospital Long Beach
      • Los Angeles, California, Vereinigte Staaten, 90048
        • Cedars-Sinai Medical Center
      • Los Angeles, California, Vereinigte Staaten, 90027
        • Children's Hospital Los Angeles
      • Madera, California, Vereinigte Staaten, 93636
        • Valley Children's Hospital
      • Oakland, California, Vereinigte Staaten, 94611
        • Kaiser Permanente-Oakland
      • Orange, California, Vereinigte Staaten, 92868
        • Children's Hospital of Orange County
      • Sacramento, California, Vereinigte Staaten, 95816
        • Sutter Medical Center Sacramento
      • Sacramento, California, Vereinigte Staaten, 95817
        • University of California Davis Comprehensive Cancer Center
      • San Diego, California, Vereinigte Staaten, 92123
        • Rady Children's Hospital - San Diego
      • San Diego, California, Vereinigte Staaten, 92134
        • Naval Medical Center -San Diego
      • Santa Barbara, California, Vereinigte Staaten, 93102
        • Santa Barbara Cottage Hospital
      • Torrance, California, Vereinigte Staaten, 90502
        • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
    • Colorado
      • Aurora, Colorado, Vereinigte Staaten, 80045
        • Children's Hospital Colorado
      • Denver, Colorado, Vereinigte Staaten, 80218
        • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
    • Connecticut
      • Hartford, Connecticut, Vereinigte Staaten, 06106
        • Connecticut Children's Medical Center
      • New Haven, Connecticut, Vereinigte Staaten, 06520
        • Yale University
    • Delaware
      • Wilmington, Delaware, Vereinigte Staaten, 19803
        • Alfred I duPont Hospital for Children
    • District of Columbia
      • Washington D.C., District of Columbia, Vereinigte Staaten, 20010
        • Children's National Medical Center
      • Washington D.C., District of Columbia, Vereinigte Staaten, 20007
        • MedStar Georgetown University Hospital
    • Florida
      • Fort Lauderdale, Florida, Vereinigte Staaten, 33316
        • Broward Health Medical Center
      • Fort Myers, Florida, Vereinigte Staaten, 33908
        • Golisano Children's Hospital of Southwest Florida
      • Gainesville, Florida, Vereinigte Staaten, 32610
        • UF Health Cancer Institute - Gainesville
      • Hollywood, Florida, Vereinigte Staaten, 33021
        • Memorial Regional Hospital/Joe DiMaggio Children's Hospital
      • Jacksonville, Florida, Vereinigte Staaten, 32207
        • Nemours Children's Clinic-Jacksonville
      • Miami, Florida, Vereinigte Staaten, 33155
        • Nicklaus Children's Hospital
      • Miami, Florida, Vereinigte Staaten, 33136
        • University of Miami Miller School of Medicine-Sylvester Cancer Center
      • Miami, Florida, Vereinigte Staaten, 33176
        • Miami Cancer Institute
      • Orlando, Florida, Vereinigte Staaten, 32827
        • Nemours Children's Hospital
      • Orlando, Florida, Vereinigte Staaten, 32803
        • AdventHealth Orlando
      • Orlando, Florida, Vereinigte Staaten, 32806
        • Arnold Palmer Hospital for Children
      • Pensacola, Florida, Vereinigte Staaten, 32504
        • Nemours Children's Clinic - Pensacola
      • St. Petersburg, Florida, Vereinigte Staaten, 33701
        • Johns Hopkins All Children's Hospital
      • Tampa, Florida, Vereinigte Staaten, 33606
        • Tampa General Hospital
      • Tampa, Florida, Vereinigte Staaten, 33607
        • Saint Joseph's Hospital/Children's Hospital-Tampa
      • West Palm Beach, Florida, Vereinigte Staaten, 33407
        • Saint Mary's Medical Center
    • Georgia
      • Atlanta, Georgia, Vereinigte Staaten, 30329
        • Children's Healthcare of Atlanta - Arthur M Blank Hospital
      • Augusta, Georgia, Vereinigte Staaten, 30912
        • Augusta University Medical Center
      • Savannah, Georgia, Vereinigte Staaten, 31404
        • Memorial Health University Medical Center
    • Hawaii
      • Honolulu, Hawaii, Vereinigte Staaten, 96826
        • Kapiolani Medical Center for Women and Children
    • Idaho
      • Boise, Idaho, Vereinigte Staaten, 83712
        • Saint Luke's Cancer Institute - Boise
    • Illinois
      • Chicago, Illinois, Vereinigte Staaten, 60637
        • University of Chicago Comprehensive Cancer Center
      • Chicago, Illinois, Vereinigte Staaten, 60612
        • University of Illinois
      • Chicago, Illinois, Vereinigte Staaten, 60611
        • Lurie Children's Hospital-Chicago
      • Maywood, Illinois, Vereinigte Staaten, 60153
        • Loyola University Medical Center
      • Oak Lawn, Illinois, Vereinigte Staaten, 60453
        • Advocate Children's Hospital-Oak Lawn
      • Park Ridge, Illinois, Vereinigte Staaten, 60068
        • Advocate Children's Hospital-Park Ridge
      • Peoria, Illinois, Vereinigte Staaten, 61637
        • OSF Children's Hospital of Illinois
      • Springfield, Illinois, Vereinigte Staaten, 62702
        • Southern Illinois University School of Medicine
    • Indiana
      • Indianapolis, Indiana, Vereinigte Staaten, 46202
        • Riley Hospital for Children
      • Indianapolis, Indiana, Vereinigte Staaten, 46260
        • Ascension Saint Vincent Indianapolis Hospital
    • Iowa
      • Des Moines, Iowa, Vereinigte Staaten, 50309
        • Blank Children's Hospital
      • Iowa City, Iowa, Vereinigte Staaten, 52242
        • University of Iowa/Holden Comprehensive Cancer Center
    • Kentucky
      • Lexington, Kentucky, Vereinigte Staaten, 40536
        • University of Kentucky/Markey Cancer Center
      • Louisville, Kentucky, Vereinigte Staaten, 40202
        • Norton Children's Hospital
    • Louisiana
      • New Orleans, Louisiana, Vereinigte Staaten, 70121
        • Ochsner Medical Center Jefferson
      • New Orleans, Louisiana, Vereinigte Staaten, 70118
        • Children's Hospital New Orleans
    • Maine
      • Bangor, Maine, Vereinigte Staaten, 04401
        • Eastern Maine Medical Center
    • Maryland
      • Baltimore, Maryland, Vereinigte Staaten, 21287
        • Johns Hopkins University/Sidney Kimmel Cancer Center
      • Baltimore, Maryland, Vereinigte Staaten, 21215
        • Sinai Hospital of Baltimore
      • Baltimore, Maryland, Vereinigte Staaten, 21201
        • University of Maryland/Greenebaum Cancer Center
      • Bethesda, Maryland, Vereinigte Staaten, 20889-5600
        • Walter Reed National Military Medical Center
    • Massachusetts
      • Boston, Massachusetts, Vereinigte Staaten, 02111
        • Tufts Children's Hospital
      • Springfield, Massachusetts, Vereinigte Staaten, 01199
        • Baystate Medical Center
      • Worcester, Massachusetts, Vereinigte Staaten, 01655
        • UMass Memorial Medical Center - University Campus
    • Michigan
      • Ann Arbor, Michigan, Vereinigte Staaten, 48109
        • C S Mott Children's Hospital
      • Detroit, Michigan, Vereinigte Staaten, 48201
        • Wayne State University/Karmanos Cancer Institute
      • Detroit, Michigan, Vereinigte Staaten, 48236
        • Henry Ford Health Saint John Hospital
      • East Lansing, Michigan, Vereinigte Staaten, 48823
        • Michigan State University
      • Flint, Michigan, Vereinigte Staaten, 48503
        • Hurley Medical Center
      • Grand Rapids, Michigan, Vereinigte Staaten, 49503
        • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
      • Kalamazoo, Michigan, Vereinigte Staaten, 49007
        • Bronson Methodist Hospital
      • Royal Oak, Michigan, Vereinigte Staaten, 48073
        • Corewell Health Children's
    • Minnesota
      • Minneapolis, Minnesota, Vereinigte Staaten, 55404
        • Children's Hospitals and Clinics of Minnesota - Minneapolis
      • Minneapolis, Minnesota, Vereinigte Staaten, 55455
        • University of Minnesota/Masonic Cancer Center
      • Rochester, Minnesota, Vereinigte Staaten, 55905
        • Mayo Clinic in Rochester
    • Mississippi
      • Jackson, Mississippi, Vereinigte Staaten, 39216
        • University of Mississippi Medical Center
    • Missouri
      • Columbia, Missouri, Vereinigte Staaten, 65212
        • University of Missouri Children's Hospital
      • Kansas City, Missouri, Vereinigte Staaten, 64108
        • Children's Mercy Hospitals and Clinics
      • St Louis, Missouri, Vereinigte Staaten, 63110
        • Washington University School of Medicine
      • St Louis, Missouri, Vereinigte Staaten, 63141
        • Mercy Hospital Saint Louis
      • St Louis, Missouri, Vereinigte Staaten, 63104
        • Cardinal Glennon Children's Medical Center
    • Nebraska
      • Omaha, Nebraska, Vereinigte Staaten, 68198
        • University of Nebraska Medical Center
      • Omaha, Nebraska, Vereinigte Staaten, 68114
        • Children's Hospital and Medical Center of Omaha
    • Nevada
      • Las Vegas, Nevada, Vereinigte Staaten, 89144
        • Summerlin Hospital Medical Center
      • Las Vegas, Nevada, Vereinigte Staaten, 89109
        • Sunrise Hospital and Medical Center
      • Las Vegas, Nevada, Vereinigte Staaten, 89135
        • Alliance for Childhood Diseases/Cure 4 the Kids Foundation
      • Las Vegas, Nevada, Vereinigte Staaten, 89102
        • University Medical Center of Southern Nevada
    • New Hampshire
      • Lebanon, New Hampshire, Vereinigte Staaten, 03756
        • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
    • New Jersey
      • Hackensack, New Jersey, Vereinigte Staaten, 07601
        • Hackensack University Medical Center
      • Morristown, New Jersey, Vereinigte Staaten, 07960
        • Morristown Medical Center
      • New Brunswick, New Jersey, Vereinigte Staaten, 08901
        • Saint Peter's University Hospital
      • New Brunswick, New Jersey, Vereinigte Staaten, 08903
        • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital
      • Newark, New Jersey, Vereinigte Staaten, 07112
        • Newark Beth Israel Medical Center
      • Paterson, New Jersey, Vereinigte Staaten, 07503
        • Saint Joseph's Regional Medical Center
    • New Mexico
      • Albuquerque, New Mexico, Vereinigte Staaten, 87106
        • University of New Mexico Cancer Center
    • New York
      • Albany, New York, Vereinigte Staaten, 12208
        • Albany Medical Center
      • Buffalo, New York, Vereinigte Staaten, 14263
        • Roswell Park Cancer Institute
      • Mineola, New York, Vereinigte Staaten, 11501
        • NYU Langone Hospital - Long Island
      • New Hyde Park, New York, Vereinigte Staaten, 11040
        • The Steven and Alexandra Cohen Children's Medical Center of New York
      • New York, New York, Vereinigte Staaten, 10065
        • Memorial Sloan Kettering Cancer Center
      • New York, New York, Vereinigte Staaten, 10029
        • Mount Sinai Hospital
      • New York, New York, Vereinigte Staaten, 10032
        • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
      • New York, New York, Vereinigte Staaten, 10065
        • NYP/Weill Cornell Medical Center
      • New York, New York, Vereinigte Staaten, 10016
        • Laura and Isaac Perlmutter Cancer Center at NYU Langone
      • Rochester, New York, Vereinigte Staaten, 14642
        • University of Rochester
      • Stony Brook, New York, Vereinigte Staaten, 11794
        • Stony Brook University Medical Center
      • Syracuse, New York, Vereinigte Staaten, 13210
        • State University of New York Upstate Medical University
      • The Bronx, New York, Vereinigte Staaten, 10467
        • Montefiore Medical Center - Moses Campus
    • North Carolina
      • Asheville, North Carolina, Vereinigte Staaten, 28801
        • Mission Hospital
      • Chapel Hill, North Carolina, Vereinigte Staaten, 27599
        • UNC Lineberger Comprehensive Cancer Center
      • Charlotte, North Carolina, Vereinigte Staaten, 28203
        • Carolinas Medical Center/Levine Cancer Institute
      • Charlotte, North Carolina, Vereinigte Staaten, 28204
        • Novant Health Presbyterian Medical Center
      • Durham, North Carolina, Vereinigte Staaten, 27710
        • Duke University Medical Center
      • Greenville, North Carolina, Vereinigte Staaten, 27834
        • East Carolina University
      • Winston-Salem, North Carolina, Vereinigte Staaten, 27157
        • Wake Forest University Health Sciences
    • North Dakota
      • Fargo, North Dakota, Vereinigte Staaten, 58122
        • Sanford Broadway Medical Center
    • Ohio
      • Akron, Ohio, Vereinigte Staaten, 44308
        • Children's Hospital Medical Center of Akron
      • Cincinnati, Ohio, Vereinigte Staaten, 45229
        • Cincinnati Children's Hospital Medical Center
      • Cleveland, Ohio, Vereinigte Staaten, 44195
        • Cleveland Clinic Foundation
      • Cleveland, Ohio, Vereinigte Staaten, 44106
        • Rainbow Babies and Childrens Hospital
      • Columbus, Ohio, Vereinigte Staaten, 43205
        • Nationwide Children's Hospital
      • Dayton, Ohio, Vereinigte Staaten, 45404
        • Dayton Children's Hospital
      • Toledo, Ohio, Vereinigte Staaten, 43606
        • ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital
    • Oklahoma
      • Oklahoma City, Oklahoma, Vereinigte Staaten, 73104
        • University of Oklahoma Health Sciences Center
    • Oregon
      • Portland, Oregon, Vereinigte Staaten, 97239
        • Oregon Health and Science University
      • Portland, Oregon, Vereinigte Staaten, 97227
        • Legacy Emanuel Children's Hospital
    • Pennsylvania
      • Allentown, Pennsylvania, Vereinigte Staaten, 18103
        • Lehigh Valley Hospital-Cedar Crest
      • Bethlehem, Pennsylvania, Vereinigte Staaten, 18017
        • Lehigh Valley Hospital - Muhlenberg
      • Danville, Pennsylvania, Vereinigte Staaten, 17822
        • Geisinger Medical Center
      • Hershey, Pennsylvania, Vereinigte Staaten, 17033
        • Penn State Children's Hospital
      • Philadelphia, Pennsylvania, Vereinigte Staaten, 19104
        • Children's Hospital of Philadelphia
      • Philadelphia, Pennsylvania, Vereinigte Staaten, 19134
        • Saint Christopher's Hospital for Children
      • Pittsburgh, Pennsylvania, Vereinigte Staaten, 15224
        • Children's Hospital of Pittsburgh of UPMC
    • Rhode Island
      • Providence, Rhode Island, Vereinigte Staaten, 02903
        • Rhode Island Hospital
    • South Carolina
      • Charleston, South Carolina, Vereinigte Staaten, 29425
        • Medical University of South Carolina
      • Columbia, South Carolina, Vereinigte Staaten, 29203
        • Prisma Health Richland Hospital
      • Greenville, South Carolina, Vereinigte Staaten, 29605
        • BI-LO Charities Children's Cancer Center
    • South Dakota
      • Sioux Falls, South Dakota, Vereinigte Staaten, 57117-5134
        • Sanford USD Medical Center - Sioux Falls
    • Tennessee
      • Chattanooga, Tennessee, Vereinigte Staaten, 37403
        • T C Thompson Children's Hospital
      • Knoxville, Tennessee, Vereinigte Staaten, 37916
        • East Tennessee Childrens Hospital
      • Nashville, Tennessee, Vereinigte Staaten, 37232
        • Vanderbilt University/Ingram Cancer Center
      • Nashville, Tennessee, Vereinigte Staaten, 37203
        • The Children's Hospital at TriStar Centennial
    • Texas
      • Austin, Texas, Vereinigte Staaten, 78723
        • Dell Children's Medical Center of Central Texas
      • Corpus Christi, Texas, Vereinigte Staaten, 78411
        • Driscoll Children's Hospital
      • Dallas, Texas, Vereinigte Staaten, 75390
        • UT Southwestern/Simmons Cancer Center-Dallas
      • Dallas, Texas, Vereinigte Staaten, 75230
        • Medical City Dallas Hospital
      • El Paso, Texas, Vereinigte Staaten, 79905
        • El Paso Children's Hospital
      • Fort Worth, Texas, Vereinigte Staaten, 76104
        • Cook Children's Medical Center
      • Houston, Texas, Vereinigte Staaten, 77030
        • UT MD Anderson Cancer Center
      • Houston, Texas, Vereinigte Staaten, 77030
        • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
      • Lubbock, Texas, Vereinigte Staaten, 79410
        • Covenant Children's Hospital
      • Lubbock, Texas, Vereinigte Staaten, 79415
        • UMC Cancer Center / UMC Health System
      • San Antonio, Texas, Vereinigte Staaten, 78229
        • University of Texas Health Science Center at San Antonio
      • San Antonio, Texas, Vereinigte Staaten, 78207
        • Children's Hospital of San Antonio
      • San Antonio, Texas, Vereinigte Staaten, 78229
        • Methodist Children's Hospital of South Texas
      • Temple, Texas, Vereinigte Staaten, 76508
        • Scott and White Memorial Hospital
    • Utah
      • Salt Lake City, Utah, Vereinigte Staaten, 84113
        • Primary Children's Hospital
    • Vermont
      • Burlington, Vermont, Vereinigte Staaten, 05405
        • University of Vermont and State Agricultural College
    • Virginia
      • Charlottesville, Virginia, Vereinigte Staaten, 22908
        • University of Virginia Cancer Center
      • Falls Church, Virginia, Vereinigte Staaten, 22042
        • Inova Fairfax Hospital
      • Norfolk, Virginia, Vereinigte Staaten, 23507
        • Children's Hospital of The King's Daughters
      • Richmond, Virginia, Vereinigte Staaten, 23298
        • VCU Massey Comprehensive Cancer Center
    • Washington
      • Seattle, Washington, Vereinigte Staaten, 98105
        • Seattle Children's Hospital
      • Spokane, Washington, Vereinigte Staaten, 99204
        • Providence Sacred Heart Medical Center and Children's Hospital
      • Tacoma, Washington, Vereinigte Staaten, 98405
        • Mary Bridge Children's Hospital and Health Center
      • Tacoma, Washington, Vereinigte Staaten, 98431
        • Madigan Army Medical Center
    • West Virginia
      • Charleston, West Virginia, Vereinigte Staaten, 25304
        • Vandalia Health/CAMC Institute for Academic Medicine
      • Morgantown, West Virginia, Vereinigte Staaten, 26506
        • West Virginia University Healthcare
    • Wisconsin
      • Green Bay, Wisconsin, Vereinigte Staaten, 54301
        • Saint Vincent Hospital Cancer Center Green Bay
      • Madison, Wisconsin, Vereinigte Staaten, 53792
        • University of Wisconsin Carbone Cancer Center - University Hospital
      • Marshfield, Wisconsin, Vereinigte Staaten, 54449
        • Marshfield Medical Center-Marshfield
      • Milwaukee, Wisconsin, Vereinigte Staaten, 53226
        • Children's Hospital of Wisconsin

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

2 Jahre bis 22 Jahre (Kind, Erwachsene)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Patients with newly diagnosed, pathologically confirmed cHL meeting one of the following Ann Arbor stages are eligible:

    • Stage IIB with bulk

    • Stage IIIB

    • Stage IVA

    • Stage IVB

      • If study eligibility by staging is uncertain, consultation with Imaging and Radiation Oncology Core (IROC) Rhode Island (RI) may be obtained prior to study enrollment
  • Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 mL/min/1.73 m^2 or a serum creatinine based on age/gender as follows (performed within 14 days prior to enrollment):

    • 2 to < 6 years: male 0.8 mg/dL, female 0.8 mg/dL
    • 6 to < 10 years: male 1 mg/dL, female 1 mg/dL
    • 10 to < 13 years: male 1.2 mg/dL, female 1.2 mg/dL
    • 13 to < 16 years: male 1.5 mg/dL, female 1.4 mg/dL
    • >= 16 years: male 1.7 mg/dL, female 1.4 mg/dL
  • Total bilirubin =< 1.5 x upper limit of normal (ULN) for age (performed within 14 days prior to enrollment)

  • Serum glutamic oxaloacetic transaminase (SGOT) (aspartate transaminase [AST]) or serum glutamate pyruvate transaminase (SGPT) (alanine transaminase [ALT]) < 2.5 x upper limit of normal (ULN) for age (performed within 14 days prior to enrollment)

  • Shortening fraction of >= 27% by echocardiogram, or ejection fraction of >= 50% by radionuclide angiogram

  • Forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) > 60% by pulmonary function test (PFT), unless due to large mediastinal mass from Hodgkin lymphoma (HL)

  • For children who are unable to cooperate for PFTs, the criteria are: no evidence of dyspnea at rest, no exercise intolerance, and a pulse oximetry reading of > 92% on room air

  • All patients and/or their parents or legal guardians must sign a written informed consent

  • All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met

Exclusion Criteria:

  • Patients with nodular lymphocyte-predominant HL
  • Patients with an immunodeficiency that existed prior to diagnosis, such as primary immunodeficiency syndromes, organ transplant recipients and children on current systemic immunosuppressive agents are not eligible
  • Patients who are pregnant; (since fetal toxicities and teratogenic effects have been noted for several of the study drugs, a negative pregnancy test is required for female patients of childbearing potential)
  • Lactating females who plan to breastfeed
  • Sexually active patients of reproductive potential who have not agreed to use an effective contraceptive method for the duration of their study participation and for 30 days after the last dose of chemotherapy
  • Patients known to be positive for human immunodeficiency virus (HIV) are not eligible
  • Patients who have received any previous chemotherapy or radiation therapy are not eligible
  • Patients who received systemic corticosteroids within 28 days of enrollment on this protocol, except as specified, are not eligible

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Aktiver Komparator: Arm I (ABVE-PC)

Patients receive doxorubicin hydrochloride IV over on days 1-2, bleomycin sulfate IV or SC on days 1 and 8, vincristine sulfate IV on days 1 and 8, etoposide IV on days 1-3, prednisone orally PO BID or methylprednisolone IV on days 1-7, and cyclophosphamide IV on days 1 and 2. Treatment repeats every 21 days for 5 cycles in the absence of disease progression or unacceptable toxicity.

Correlative studies

Ancillary studies

Andere Namen:
  • Bewertung der Lebensqualität

Given IV

Andere Namen:
  • Cytoxan
  • CTX
  • (-)-Cyclophosphamid
  • 2H-1,3,2-Oxazaphosphorin, 2-[Bis(2-chlorethyl)amino]tetrahydro-, 2-Oxid, Monohydrat
  • Carloxan
  • Ciclofosfamida
  • Ciclofosfamid
  • Cicloxal
  • Clafen
  • Claphene
  • CP-Monohydrat
  • CYCLO-Zelle
  • Cycloblastin
  • Cyclophospham
  • Cyclophosphamid-Monohydrat
  • Cyclophosphamid
  • Cyclophosphan
  • Cyclophosphanum
  • Cyclostin
  • Cytophosphan
  • Fosfaseron
  • Genoxal
  • Genuxal
  • Ledoxina
  • Mitoxan
  • Neosar
  • Revimmun
  • Syklofosfamid
  • WR-138719
  • Asta B 518
  • B-518
  • B 518
  • B518
  • WR 138719
  • WR138719
  • Frindovyx

Given IV

Andere Namen:
  • Adriamycin
  • 5,12-Naphthacendion, 10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy -8-(Hydroxyacetyl)-1-methoxy-, Hydrochlorid, (8S-cis)-(9CI)
  • ADM
  • Adriacin
  • Adriamycinhydrochlorid
  • Adriamycin PFS
  • Adriamycin RDF
  • ADRIAMYCIN, HYDROCHLORID
  • Adriblastina
  • Adriblastin
  • Adrimedac
  • Chloridrato de Doxorrubicina
  • DOX
  • DOXO-ZELLE
  • Doxolem
  • Doxorubicin-HCl
  • Doxorubicin.HCl
  • Doxorubin
  • Farmiblastina
  • FI 106
  • FI-106
  • Hydroxydaunorubicin
  • Rubex
  • FI106

Given PO

Andere Namen:
  • Deltason
  • Orason
  • Δ1-Cortison
  • 1, 2-Dehydrocortison
  • Adamon
  • Cortancyl
  • Dacortin
  • DeCortin
  • Decortisyl
  • Decorton
  • Delta 1-Cortison
  • Delta-Kuppel
  • Deltacorten
  • Deltacortison
  • Deltadehydrocortison
  • Deltison
  • Delta
  • Econoson
  • Lisacort
  • Meprosona-F
  • Metacortandracin
  • Meticorten
  • Ofisolona
  • Panafcort
  • Panasol-S
  • Parakort
  • Perrigo Prednison
  • PRED
  • Prädiktor
  • Prädicorten
  • Prednicen-M
  • Prednikort
  • Prednidib
  • Prednilonga
  • Vorurteil
  • Prednison Intensol
  • Prednisonum
  • Predniton
  • Promifen
  • Strahlen
  • Service
  • SK-Prednison

Given IV

Andere Namen:
  • Oncovin
  • Kyokristin
  • Leurocristinsulfat
  • Leurocristin, Sulfat
  • Vincasar
  • Vincosid
  • Vincrex
  • Vincristin, Sulfat

Ancillary studies

Given IV

Andere Namen:
  • Demethyl Epipodophyllotoxin Ethylidinglucosid
  • EPEG
  • Lastet
  • Toposar
  • Vepesid
  • VP 16
  • VP 16-213
  • VP-16
  • VP-16-213
  • VP16
  • VP 16213
  • VP-16213
  • VP16213

Correlative studies

Given IV or SC

Andere Namen:
  • Blocin
  • Blenoxan
  • Blanoxan
  • BleMomycin
  • Bleo-Zelle
  • Bleo-S
  • Bleolem
  • Bleomycin-Sulfate
  • Bleomycinsulfat
  • Bleomycini-Sulfas
  • Blexane
  • Öl Bleo

Given IV

Andere Namen:
  • Medrol
  • Wyacort
  • Adlone
  • Caberdelta M
  • DepMedalone
  • Depot Moderin
  • Depo-Nisolon
  • Duralone
  • Emmetipi
  • Esaton
  • Firmacort
  • Medlone 21
  • Medrate
  • Medrol Veriderm
  • Medrone
  • Mega-Star
  • Meprolon
  • Methylprednisolon
  • Metilbetason löslich
  • Metrocort
  • Metapresol
  • Metysolon
  • Predni-M-Tablinen
  • Prednilen
  • Radilem
  • Sieropresol
  • Solpredone
  • Summicort
  • Urbason
  • Veriderm Medrol
Experimental: ARM II (Bv-AVEPC)

Patients receive brentuximab vedotin IV on day 1. Patients also receive doxorubicin hydrochloride, etoposide, prednisone or methylprednisolone, and cyclophosphamide as in Arm I and vincristine sulfate IV on day 8. Treatment repeats every 21 days for 5 cycles in the absence of disease progression or unacceptable toxicity.

Correlative studies

Ancillary studies

Andere Namen:
  • Bewertung der Lebensqualität

Given IV

Andere Namen:
  • Cytoxan
  • CTX
  • (-)-Cyclophosphamid
  • 2H-1,3,2-Oxazaphosphorin, 2-[Bis(2-chlorethyl)amino]tetrahydro-, 2-Oxid, Monohydrat
  • Carloxan
  • Ciclofosfamida
  • Ciclofosfamid
  • Cicloxal
  • Clafen
  • Claphene
  • CP-Monohydrat
  • CYCLO-Zelle
  • Cycloblastin
  • Cyclophospham
  • Cyclophosphamid-Monohydrat
  • Cyclophosphamid
  • Cyclophosphan
  • Cyclophosphanum
  • Cyclostin
  • Cytophosphan
  • Fosfaseron
  • Genoxal
  • Genuxal
  • Ledoxina
  • Mitoxan
  • Neosar
  • Revimmun
  • Syklofosfamid
  • WR-138719
  • Asta B 518
  • B-518
  • B 518
  • B518
  • WR 138719
  • WR138719
  • Frindovyx

Given IV

Andere Namen:
  • Adriamycin
  • 5,12-Naphthacendion, 10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy -8-(Hydroxyacetyl)-1-methoxy-, Hydrochlorid, (8S-cis)-(9CI)
  • ADM
  • Adriacin
  • Adriamycinhydrochlorid
  • Adriamycin PFS
  • Adriamycin RDF
  • ADRIAMYCIN, HYDROCHLORID
  • Adriblastina
  • Adriblastin
  • Adrimedac
  • Chloridrato de Doxorrubicina
  • DOX
  • DOXO-ZELLE
  • Doxolem
  • Doxorubicin-HCl
  • Doxorubicin.HCl
  • Doxorubin
  • Farmiblastina
  • FI 106
  • FI-106
  • Hydroxydaunorubicin
  • Rubex
  • FI106

Given PO

Andere Namen:
  • Deltason
  • Orason
  • Δ1-Cortison
  • 1, 2-Dehydrocortison
  • Adamon
  • Cortancyl
  • Dacortin
  • DeCortin
  • Decortisyl
  • Decorton
  • Delta 1-Cortison
  • Delta-Kuppel
  • Deltacorten
  • Deltacortison
  • Deltadehydrocortison
  • Deltison
  • Delta
  • Econoson
  • Lisacort
  • Meprosona-F
  • Metacortandracin
  • Meticorten
  • Ofisolona
  • Panafcort
  • Panasol-S
  • Parakort
  • Perrigo Prednison
  • PRED
  • Prädiktor
  • Prädicorten
  • Prednicen-M
  • Prednikort
  • Prednidib
  • Prednilonga
  • Vorurteil
  • Prednison Intensol
  • Prednisonum
  • Predniton
  • Promifen
  • Strahlen
  • Service
  • SK-Prednison

Given IV

Andere Namen:
  • Oncovin
  • Kyokristin
  • Leurocristinsulfat
  • Leurocristin, Sulfat
  • Vincasar
  • Vincosid
  • Vincrex
  • Vincristin, Sulfat

Ancillary studies

Given IV

Andere Namen:
  • Adcetris
  • SGN-35
  • cAC10-vcMMAE
  • ADC SGN-35
  • Anti-CD30-Antikörper-Wirkstoff-Konjugat SGN-35
  • Monoklonaler Anti-CD30-Antikörper-MMAE SGN-35
  • Monoklonaler Anti-CD30-Antikörper-Monomethylauristatin E SGN-35
  • SGN35
  • SGN 35

Given IV

Andere Namen:
  • Demethyl Epipodophyllotoxin Ethylidinglucosid
  • EPEG
  • Lastet
  • Toposar
  • Vepesid
  • VP 16
  • VP 16-213
  • VP-16
  • VP-16-213
  • VP16
  • VP 16213
  • VP-16213
  • VP16213

Correlative studies

Given IV

Andere Namen:
  • Medrol
  • Wyacort
  • Adlone
  • Caberdelta M
  • DepMedalone
  • Depot Moderin
  • Depo-Nisolon
  • Duralone
  • Emmetipi
  • Esaton
  • Firmacort
  • Medlone 21
  • Medrate
  • Medrol Veriderm
  • Medrone
  • Mega-Star
  • Meprolon
  • Methylprednisolon
  • Metilbetason löslich
  • Metrocort
  • Metapresol
  • Metysolon
  • Predni-M-Tablinen
  • Prednilen
  • Radilem
  • Sieropresol
  • Solpredone
  • Summicort
  • Urbason
  • Veriderm Medrol

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Event Free Survival (EFS), Where Events Include Disease Progression or Relapse, Second Malignancy, or Death
Zeitfenster: Up to 48 months after the last enrollment

Primary analysis will be based 1-sided log rank test comparison of EFS curves between the 2 randomized arms per intention-to-treat principle. Progression is defined as an ≥50% increase of in the product of the perpendicular diameters of any of the involved nodes or nodal masses or focal organ lesions in sites that were persistently PET positive; or recurrent PET positive lesions (Deauville 4, 5) in sites that had previously been PET negative regardless of change of size, as was the development of new PET avid measurable lesion(s) >1.5cm in any axis, or new sites of assessable disease. Relapse is defined in patients who achieved a prior CR but subsequently has an increase of ≥50% of the PPD in prior nodal or extranodal sites in a recurrently PET positive lesion(s), or the development of new measurable lesion(s) >1.5cm in any axis, or new sites of assessable disease. Second malignancy is defined based on report of a cancer that is not considered to be classic Hodgkin Lymphoma.

Up to 48 months after the last enrollment

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Percentages of Patients With Early Response Defined as no Slow Responding Lesions (SRL) and no Progressive Disease (PD) at Any Disease Sites Determined by Positron Emission Tomography (PET) Per Deauville Criteria Through Central Review
Zeitfenster: After 42 days of chemotherapy

The percentages of patients (with available PET scan) with no SRL and no PD will be compared between the two randomized arms to see if brentuximab vedotin in the chemotherapy backbone of doxorubicin hydrochloride, vincristine sulfate, etoposide, prednisone and cyclophosphamide (Bv-AVEPC) arm has a higher rate of early response compared to doxorubicin hydrochloride, bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide (ABVE-PC) arm. Two-sample Z test of proportions at 1-sided alpha level of 0.05 will be used for these comparisons.

After 42 days of chemotherapy
Percentages of Patients Experiencing Grade 3+ Peripheral Neuropathy Assessed by Modified Balis Scale
Zeitfenster: From the enrollment of the patient to the time of analysis or the last follow-up; an average of 3.6 years.

The percentages of patients experiencing grade 3+ peripheral neuropathy assessed by the treating clinician using the modified Balis scale. The "Modified Balis scale of Pediatric Neuropathy" allows clinicians to assign a score for sensory or motor neuropathy symptoms separately. Scores range from 1 to 4 with 1 being the least symptomatic state and 4 indicating a severe debility. The percentages of patients (with a score >/=3) will be compared between the 2 arms by two-sample Z test at 1-sided alpha level of 0.05.

From the enrollment of the patient to the time of analysis or the last follow-up; an average of 3.6 years.

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Childhood International Prognostic Score (CHIPS) Score
Zeitfenster: Baseline

CHIPS will be computed for all patients and summarized by descriptive statistics. Will examine the association between CHIPS and early response by cross-tabulations and Chi-square tests within each arm separately, as well as logistic regression model where early response is the outcome variable and CHIPS the predictor variable combining the 2 arms with adjustment for randomized chemotherapy.

Baseline
Dose of Radiation Received by Normal Tissues Following Chemotherapy on Either Study Arm
Zeitfenster: Up to 48 months

Descriptive statistics will be used to summarize RT doses received by normal tissues on this study. Two-sample t-test will be used to compare the doses received on this study to those on prior studies.

Up to 48 months
Efficacy of Involved Site Radiotherapy (ISRT) by Analyzing the Event-free Survival of Patients Treated With Response-adapted ISRT and by Evaluating Patterns of Relapse Following ISRT
Zeitfenster: Up to 3 years

EFS for patients on each arm as well as those receiving ISRT or those with slow early response (SER) on each arm will be estimated. One-sample log rank test will be used to compare the observed EFS to the assumed baseline of 82% at 3 years to see if the observed EFS is significantly lower than the projection in these subsets.

Up to 3 years
Risk of Relapse Among RRL Subjects That Have at Least One Lesion That is Deauville 3 at PET 2
Zeitfenster: Up to 48 months after the last enrollment

The risk of relapse for cases that are RRL, but have Deauville 3 lesions, will be compared to those that are classified as complete metabolic response at PET2 with solely Deauville 1 or 2 lesions with K-sample test.

Up to 48 months after the last enrollment
Pharmacokinetic (PK) Analyses
Zeitfenster: Pre-dose and end of infusion on day 1, days 2, 3, 8, and 15 of cycle 4 and pre-dose on day 1 and day 22 of cycle 5 (each cycle = 21 days)

PK concentration time profile will be evaluated.

Pre-dose and end of infusion on day 1, days 2, 3, 8, and 15 of cycle 4 and pre-dose on day 1 and day 22 of cycle 5 (each cycle = 21 days)

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Ermittler

  • Hauptermittler: Sharon M Castellino, Children's Oncology Group

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

19. März 2015

Primärer Abschluss (Tatsächlich)

31. Dezember 2021

Studienabschluss (Geschätzt)

14. Oktober 2027

Studienanmeldedaten

Zuerst eingereicht

16. Juni 2014

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

16. Juni 2014

Zuerst gepostet (Geschätzt)

18. Juni 2014

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

13. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

10. November 2026

Zuletzt verifiziert

1. Juni 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • NCI-2014-01223
  • U10CA180886 (US NIH Stipendium/Vertrag)
  • NCI-2014-01223 (Registrierungskennung: CTRP (Clinical Trial Reporting Program))
  • s15-00950
  • AHOD1331 (Andere Kennung: CTEP)
  • AHOD1331 (Andere Kennung: Children's Oncology Group)

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .